Skip to main content
. Author manuscript; available in PMC: 2020 Feb 22.
Published in final edited form as: J Autism Dev Disord. 2019 Sep;49(9):3656–3668. doi: 10.1007/s10803-019-04085-y

Table 1.

Participant demographics and clinical characteristics

Variable Total sample ASD subgroups based on disruptive behavior (DB)
Healthy controls
n = 44
Disruptive behavior
n = 79
ASD
n = 63
p value With DB (ASD/DB+)
n = 22
Without DB (ASD/DB−)
n = 41
p value
Age, years (SD) 12.3 (1.8) 11.7 (2.1) 12.4 (1.9) .09 12.5 (2) 12.3 (1.9) .74
Male (n, %) 29 (65.9) 54 (68.4) 47 (74.6) .58 17 (77.3) 30 (73.2) .72
Mean IQa (SD) 111.3 (10) 105.8 (13.7) 104.9 (19.1) .07 103.7 (16.8) 105.6 (20.3) .71
Race (n, %) .13 .09
 White 28 (63.6) 58 (73.4) 54 (85.7) 18 (81.8) 36 (87.8)
 Black 9 (20.5) 11 (13.9) 2 (3.2) 2 (9.1) 0
 Asian/Pacific Islander 1 (2.3) 1 (1.3) 1 (1.6) 1 (4.5) 0
 American Indian/Alaska Native 0 2 (2.5) 0 0 0
 Other/more than one race 6 (13.6) 7 (8.9) 6 (9.5) 1 (4.5) 5 (12.2)
Ethnicity (n, %) .45 .41
 Hispanic 5 (11.4) 14 (17.7) 7 (11.1) 1 (4.5) 6 (14.6)
 Non-Hispanic 39 (88.6) 65 (82.3) 55 (88.7) 21 (95.5) 35 (85.4)
Mean CBCL aggression T score (SD) 50.5 (1.8) 75.3 (7.2) 60.8 (11.2) < .001bc 72.9 (8.6) 54.4 (5.8) < .001b
Mean RPQ aggression total score (SD) 2.5 (2.2) 19.5 (6.7) 10.1 (7.9) < .001bc 17.5 (7.8) 6.1 (4.3) < .001b
Mean SRS-2 total T score (SD) 45 (5.7) 62.3 (10.6) 73.5 (9.5) < .001bd 79.2 (7.6) 70.5 (9.2) < .001b
 Social communication interaction scale 45 (7.7) 63.1 (10.3) 73.3 (9.8) < .001bd 78.5 (8.1) 70.4 (9.6) .001b
 Restricted and repetitive behaviors scale 43.8 (3.8) 58.4 (11.2) 71.9 (10.8) < .001bd 79.4 (7.7) 67.9 (10.2) < .001b
Mean ADOS-2 module 3 total score (SD) 13.2 (4.2) 15.2 (4.1) 12.1 (3.9) .005b
 Social affect scale 10.7 (3.7) 11.9 (3.4) 9.9 (3.7) .04b
 Restricted and repetitive behaviors scale 2.6 (1.7) 3.3 (1.7) 2.2 (1.6) .01b
Mean ADI-R subscale scores (SD)
 Social interaction 19.5 (5.3) 20.2 (5.4) 19.2 (5.2) .47
 Communication 15.3 (3.8) 15.5 (3.5) 15.2 (3.9) .76
DSM-5 diagnosis (n, %)
 Oppositional defiant disorder 56 (70.9) 22 (28.2) < .001b 22 (100) 0 < .001b
 Conduct disorder 3 (3.8) 0 .25 0 0
 Disruptive behavior disorder NOS 4 (5.1) 0 .13 0 0
 Disruptive mood dysregulation disorder 17 (21.5) 0 < .001b 0 0
 Attention-deficit/hyperactivity disorder 60 (75.9) 35 (55.6) .01b 19 (86.4) 16 (39) < .001b
 Anxiety disorder 19 (24.1) 33 (52.4) .001b 9 (40.9) 24 (58.5) .18
 Depressive disorder 5 (6.3) 3 (4.8) 1 0 3 (7.3) .54
Currently taking medication (n, %) 34 (43) 29 (46) < .001b 16 (72.7) 13 (31.7) .002b
Type of medication (n, %)
 Stimulants 25 (31.6) 12 (19) .09 7 (31.8) 5 (12.2) .09
 Non-stimulants 15 (19) 9 (14.3) .46 7 (31.8) 2 (4.9) .006b
 Antidepressant 9 (11.4) 11 (17.5) .30 6 (27.3) 5 (12.2) .17
 Neuroleptics 7 (8.9) 5 (7.9) .84 4 (18.2) 1 (2.4) .04b
 Mood stabilizers 0 3 (4.8) .09 3 (13.6) 0 .04b
 Benzodiazepines 0 2 (3.2) .19 2 (9.1) 0 .12

Disruptive behavior group refers to children with disruptive behavior disorder without ASD

ASD/DB+, autism spectrum disorder with co-occurring disruptive behavior disorder; ASD/DB−, autism spectrum disorder without disruptive behavior disorder; ADI-R, autism diagnostic interview-revised; ADOS-2, autism diagnostic observation schedule-2nd edition; CBCL, child behavior checklist; RPQ, reactive–proactive aggression questionnaire; SRS-2, social responsiveness scale-second edition

a

Full-scale IQ measured by the Wechsler abbreviated scale of intelligence (Wechsler 1997) or the differential ability scales-II (Elliott 2007)

b

Significant group differences at p < 0.05, Bonferroni corrected, except for Chi square test for categorical variables and independent samples T test

c

ASD > healthy controls; disruptive behavior > healthy controls; disruptive behavior > ASD

d

ASD > healthy controls; ASD > disruptive behavior; disruptive behavior > healthy controls